Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00698854 · ClinicalTrials.gov registry record

A Clinical Investigation of the Vanguard™ Complete Knee System

A clinical trial, sponsored by Zimmer Biomet.

Completed
Registry status
552
Enrollment target

NCT00698854 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 552 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00698854 has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
552 participants
Enrollment target

Study Summary

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.

Interventions

  • DEVICE Vanguard™ Complete Knee System
  • DEVICE Vanguard™ Patient-Specific Femur

Trial Details

FieldValue
Enrollment Target 552 participants
Start Date 2004-03
Est. Completion 2024-03

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT00698854

The ClinicalTrials.gov registry entry for NCT00698854 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 552 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vanguard™ Complete Knee System is the first listed.

NCT00698854 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00698854 about?

NCT00698854 is a clinical study titled "A Clinical Investigation of the Vanguard™ Complete Knee System". The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.

What is the current status of trial NCT00698854?

This trial is currently completed. The enrollment target is 552 participants. The study started on 2004-03. Estimated completion is 2024-03.

What interventions are being tested in trial NCT00698854?

The interventions under investigation include: Vanguard™ Complete Knee System (DEVICE), Vanguard™ Patient-Specific Femur (DEVICE).

Who is sponsoring clinical trial NCT00698854?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.